Gene therapy to treat amyotrophic lateral sclerosis
Using gene therapy to address amyotrophic lateral sclerosis. That is the ambitious project currently being conducted by Avrion Therapeutics AG and the Laboratory for Neural Genetics and Disease at EPFL, supported by Innosuisse. Promising research is currently underway using a combination of technologies, including genome engineering and artificial intelligence, beginning with a model organism, the fruit fly Drosophila. The work could lead to the development of novel treatments for this incurable disease.